|
According to CCTV, "Weekly Quality Report" report, a factory price of 15.5 yuan of medicines, through pharmaceutical companies, pharmaceutical representatives, doctors and other sectors, the final sale price went up 213 yuan to the hands of patients, up to 1300% profit. Press survey found that, in this session, doctors prescribe the most profitable. Hunan's largest hospitals of the Second Xiangya Hospital drug procurement executives in charge of pharmacists Zhou Hong told reporters, price 213 yuan, is determined by the state. All hospital drug prices are the price department of Hunan Province after approval, and required bidding. According to our pricing policy provides medical care, the hospital bought the Cost Price of each drug can be sold on the increase of 15% of patients. 2010 in Hunan province's inquiry focused on guiding the procurement tender offer price of drugs and found that asparagus is 136 pieces of guidance prices. Second Xiangya Hospital, the actual increase of 56%, far exceeds the 15% set by the state. ("Beijing News" May 17) Profit of 1,300% profits! Absolutely huge profits! Drug prices "tumbling cloud", due to chaos in market supervision. Ex-factory price of medicines is only 15.5 yuan, through pharmaceutical companies, pharmaceutical representatives, doctors and other sectors, the final sale price rose to 213 yuan to the hands of patients, this strange phase highlights the confusion in the current pharmaceutical market regulation. Pharmaceutical market to have such a huge profit difference can be said is completely relevant, or poor supervision, lack of supervision caused. Resulting in a "sick pharmaceutical market, the patient pays the bill to come to" chaos. In accordance with our general understanding of products from manufacturers to the hands of consumers in general after the factory - wholesale - retail and three links on it, but drugs is different, not the wholesalers buy from manufacturers out there, but by pharmaceutical companies, medical representatives, medical and many other aspects, the most important thing is, these sectors are not the normal fare, but are to use "rebate", and drugs has a price, but the "rebate" is priceless, eventually led to drugs sold as "unlimited." Can be said that numerous aspects of drug sales, price confusion is leading to the high price of China's pharmaceutical market, the crux of patient burden. Through the layers increases, the price of drugs and even the "tumbling cloud," ex-factory price of drugs sold 15.5 yuan 213 yuan is not surprising. It also witnessed China precisely regulated pharmaceutical market chaos. It can be said, is the lack of supervision by government departments was a result of confusion in the pharmaceutical market, only intensified the burden on patients, the government and its departments are in-depth reflection. Why in the sales cycle, the drugs can not be the same as other commodities, to simplify it? 15% of each link in accordance with the provisions of the fare increase, from pharmaceutical to pharmaceutical companies to medical representatives to doctors and then to the hospital, medicine has increase 60% rebate if you count each link to take the money, the price of drugs can be imagined cicada. That our medicines have been sold in this mode, resulting in patients with high drug prices over the years has been the weight of kick but up. Regulatory confusion that the pharmaceutical market is the relevant price of drugs is not well known for, but like "Mangrenmoxiang." For example, centralized purchasing drugs Hunan 2010 guide price tender offer, this ex-factory price of 15.5 yuan asparagus pieces, the guided price was set at 136 yuan, did not know this "guidance prices" is directed by the department, but also is what "guidance" from the price? Obviously, this guidance prices are not set according to the manufacturer ex-factory price, as is what "guidance", only "guidance department" clear his mind. To listen only on behalf of pharmaceutical companies or medical or hospital side of the story, laid out a "guidance prices", this sector, but also how much responsibility? This sector, but also expect them to think of the people work it? In recent years, due to high medical costs, high cost of medicine, leading to patients of coverage, could not afford medicines, the departments concerned have also been clamoring for medical reform, some proposals to change the hospital system, and some suggestions for reducing the medical costs " to drug dependent doctors, "changing the results to the patient did not reduce the cost of one point, the opposite is also heavier than before! Of "drug dependent doctors," the way "really good", ex-factory price of drugs sold on the 15.5 yuan 213 yuan, of course, to achieve the "drug dependent treatment" purposes! Only, so the "drug dependent doctors" fat of the hospitals and doctors, but misery to the people! Can be said that drug prices will remain at a fair and reasonable price, is the largest medical reform success! Therefore, the key to medical reform, in addition to the necessary reforms in hospital, it also should reform the regulatory sector, the relevant departments to take up the responsibility of monitoring and increase the pharmacy market. The e-commerce company in China offers quality products such as precision turbo parts Manufacturer , journal bearing turbo Manufacturer, and more. For more , please visit turbos direct today!
Related Articles -
precision turbo parts Manufacturer, journal bearing turbo Manufacturer,
|
